Common Genetic Variation and Risk of Osteosarcoma in a Multi-ethnic Pediatric and Adolescent Population
Overview
Authors
Affiliations
Osteosarcoma, a malignant primary bone tumor most commonly diagnosed in children and adolescents, has a poorly understood genetic etiology. Genome-wide association studies (GWAS) and candidate-gene analyses have identified putative risk variants in subjects of European ancestry. However, despite higher incidence among African-American and Hispanic children, little is known regarding common heritable variation that contributes to osteosarcoma incidence and clinical presentation across racial/ethnic groups. In a multi-ethnic sample of non-Hispanic white, Hispanic, African-American and Asian/Pacific Islander children (537 cases, 2165 controls), we performed association analyses assessing previously-reported loci for osteosarcoma risk and metastasis, including meta-analysis across racial/ethnic groups. We also assessed a previously described association between genetic predisposition to longer leukocyte telomere length (LTL) and osteosarcoma risk in this independent multi-ethnic dataset. In our sample, we were unable to replicate previously-reported loci for osteosarcoma risk or metastasis detected in GWAS of European-ancestry individuals in either ethnicity-stratified analyses or meta-analysis across ethnic groups. Our analyses did confirm that genetic predisposition to longer LTL is a risk factor for osteosarcoma (OR: 1.22; 95% CI: 1.09-1.36; P = 3.8 × 10), and the strongest effect was seen in Hispanic subjects (OR: 1.32; 95% CI: 1.12-1.54, P = 6.2 × 10). Our findings shed light on the replicability of osteosarcoma risk loci across ethnicities and motivate further characterization of these genetic factors in diverse clinical cohorts.
A Review of Limbic System-Associated Membrane Protein in Tumorigenesis.
Sinopole K, Babcock K, Dobi A, Petrovics G Biomedicines. 2024; 12(11).
PMID: 39595156 PMC: 11591814. DOI: 10.3390/biomedicines12112590.
Telomeres and telomerase in Sarcoma disease and therapy.
Huang J, Feng Y, Shi Y, Shao W, Li G, Chen G Int J Med Sci. 2024; 21(11):2065-2080.
PMID: 39239547 PMC: 11373546. DOI: 10.7150/ijms.97485.
Circulating immune cells and risk of osteosarcoma: a Mendelian randomization analysis.
Li L, Sun Y, Luo J, Liu M Front Immunol. 2024; 15:1381212.
PMID: 39081321 PMC: 11286390. DOI: 10.3389/fimmu.2024.1381212.
Lucas S, Yang T, Wimberly C, Parmar K, Hansen H, de Smith A Cancer Epidemiol. 2024; 92:102599.
PMID: 38871555 PMC: 11402579. DOI: 10.1016/j.canep.2024.102599.
Unraveling the causal genes and transcriptomic determinants of human telomere length.
Chang Y, Zhou Y, Zhou J, Li W, Cao J, Jing Y Nat Commun. 2023; 14(1):8517.
PMID: 38129441 PMC: 10739845. DOI: 10.1038/s41467-023-44355-z.